DTSQ = Diabetes Treatment Satisfaction Questionnaire
Regulatory agencies (FDA and European Medicines Agency) conducted exhaustive reviews and concluded theres no causal relationship
Reuben A, Spencer CN, Prieto PA, Gopalakrishnan V, Reddy SM, Miller JP, Mao X, De Macedo MP, Chen J, Song X, Jiang H, Chen PL, Beird HC, Garber HR, Roh W, Wani K, Chen E, Haymaker C, Forget MA, Little LD, Gumbs C, Thornton RL, Hudgens CW, Chen WS, Austin-Breneman J, Sloane RS, Nezi L, Cogdill AP, Bernatchez C, Roszik J, Hwu P, Woodman SE, Chin L, Tawbi H, Davies MA , Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Tetzlaff MT, Lazar AJ, Wistuba II, Clise-Dwyer K, Carter BW, Zhang J, Futreal PA, Sharma P, Allison JP, Cooper ZA, Wargo JA
Pleasesee ourFrequently Asked Questionsfor answers to commonly asked questions about our PatchAid vitamin patches
2024:e13700
Carmot Therapeutics is also advancing preclinical programs targeting PYY, a peptide for potentially treating Prader Willi syndrome and other metabolic diseases in conjunction with other incretin agonists
